CLMar 18

PACE-RAG: Patient-Aware Contextual and Evidence-based Policy RAG for Clinical Drug Recommendation

arXiv:2603.1735676.1h-index: 5Has Code
AI Analysis

This addresses personalized clinical decision support for patients with complex conditions, representing a domain-specific incremental improvement over existing RAG methods.

The paper tackles the problem of drug recommendation for complex conditions like Parkinson's disease by proposing PACE-RAG, a framework that synthesizes individual patient context with prescribing patterns of similar cases, achieving state-of-the-art F1 scores of 80.84% on a Parkinson's cohort and 47.22% on the MIMIC-IV benchmark.

Drug recommendation requires a deep understanding of individual patient context, especially for complex conditions like Parkinson's disease. While LLMs possess broad medical knowledge, they fail to capture the subtle nuances of actual prescribing patterns. Existing RAG methods also struggle with these complexities because guideline-based retrieval remains too generic and similar-patient retrieval often replicates majority patterns without accounting for the unique clinical nuances of individual patients. To bridge this gap, we propose PACE-RAG (Patient-Aware Contextual and Evidence-based Policy RAG), a novel framework designed to synthesize individual patient context with the prescribing tendencies of similar cases. By analyzing treatment patterns tailored to specific clinical signals, PACE-RAG identifies optimal prescriptions and generates an explainable clinical summary. Evaluated on a Parkinson's cohort and the MIMIC-IV benchmark using Llama-3.1-8B and Qwen3-8B, PACE-RAG achieved state-of-the-art performance, reaching F1 scores of 80.84% and 47.22%, respectively. These results validate PACE-RAG as a robust, clinically grounded solution for personalized decision support. Our code is available at: https://github.com/ChaeYoungHuh/PACE-RAG.

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes